Serological and experimental studies in different forms of myasthenia gravis

IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders

(2018) Maartje G. Huijbers et al.   Annals of the New York Academy of Sciences

Myasthenic syndromes due to defects in COL13A1 and in the N-linked glycosylation pathway

(2018) David Beeson et al.   Annals of the New York Academy of Sciences

The unfolding landscape of the congenital myasthenic syndromes

(2018) Andrew G. Engel et al.   Annals of the New York Academy of Sciences

Multiple antibody detection in ‘seronegative’ myasthenia gravis patients

(2017) Y. Hong et al.   EUROPEAN JOURNAL OF NEUROLOGY

Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis

(2017) Shuuichi Mori et al.   EXPERIMENTAL NEUROLOGY

IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients

(2017) Inga Koneczny et al.   JOURNAL OF AUTOIMMUNITY

Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis

(2017) Isabell Cordts et al.   JOURNAL OF NEUROLOGY

Titin antibodies in “seronegative” myasthenia gravis — A new role for an old antigen

(2016) C. Stergiou et al.   JOURNAL OF NEUROIMMUNOLOGY

Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort

(2016) Saif Huda et al.   MUSCLE & NERVE

Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

(2016) Elena Cortés-Vicente et al.   JAMA Neurology

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis

(2015) Pedro M. Rodríguez Cruz et al.   JAMA Neurology

Cortactin autoantibodies in myasthenia gravis

(2014) Eduard Gallardo et al.   AUTOIMMUNITY REVIEWS

Autoantibodies to Agrin in Myasthenia Gravis Patients

(2014) Bin Zhang et al.   PLoS One

Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase

(2013) Amelia Evoli et al.   AUTOIMMUNITY REVIEWS

Antibodies to clustered acetylcholine receptor: expanding the phenotype

(2013) P. Devic et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies

(2013) S. Suzuki et al.   EUROPEAN JOURNAL OF NEUROLOGY

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

(2013) P. Zisimopoulou et al.   JOURNAL OF AUTOIMMUNITY

Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients: Table 1

(2013) Benison Keung et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters

(2013) Inga Koneczny et al.   PLoS One

MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4

(2013) M. G. Huijbers et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Role of MuSK in Synapse Formation and Neuromuscular Disease

(2013) S. J. Burden et al.   Cold Spring Harbor Perspectives in Biology

LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients

(2013) John S. Tzartos et al.   Annals of Clinical and Translational Neurology

Antibodies identified by cell-based assays in myasthenia gravis and associated diseases

(2012) Angela Vincent et al.   Annals of the New York Academy of Sciences

The search for new antigenic targets in myasthenia gravis

(2012) Judith Cossins et al.   Annals of the New York Academy of Sciences

Presence and Pathogenic Relevance of Antibodies to Clustered Acetylcholine Receptor in Ocular and Generalized Myasthenia Gravis

(2012) Saiju Jacob et al.   ARCHIVES OF NEUROLOGY

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice

(2012) Rinse Klooster et al.   BRAIN

Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects

(2012) Stuart Viegas et al.   EXPERIMENTAL NEUROLOGY

Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses

(2012) Norihiro Yumoto et al.   NATURE

Long-lasting treatment effect of rituximab in MuSK myasthenia

(2012) J. Diaz-Manera et al.   NEUROLOGY

Distinct Roles of Muscle and Motoneuron LRP4 in Neuromuscular Junction Formation

(2012) Haitao Wu et al.   NEURON

Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis

(2011) Fredrik Romi et al.   JOURNAL OF NEUROLOGY

A systematic review of population based epidemiological studies in Myasthenia Gravis

(2010) Aisling S Carr et al.   BMC Neurology

Use and monitoring of low dose rituximab in myasthenia gravis

(2010) S. Blum et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The Cytoplasmic Adaptor Protein Dok7 Activates the Receptor Tyrosine Kinase MuSK via Dimerization

(2010) Elisa Bergamin et al.   MOLECULAR CELL

Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies

(2008) Angela Vincent et al.   Annals of the New York Academy of Sciences

Myasthenia Gravis in the Elderly

(2008) Johan A. Aarli   Annals of the New York Academy of Sciences

The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters

(2008) Yueping K Qian et al.   BMC NEUROSCIENCE

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†

(2008) Maria Isabel Leite et al.   BRAIN

Successful treatment of refractory generalized myasthenia gravis with rituximab

(2008) C. Lebrun et al.   EUROPEAN JOURNAL OF NEUROLOGY

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients

(2008) Isabel Illa et al.   JOURNAL OF NEUROIMMUNOLOGY